1 / 12

Preventing Falls Among Older Adults: The Role of the Community Pharmacist

Preventing Falls Among Older Adults: The Role of the Community Pharmacist. David A. Mott, PhD Barb Michaels, RN Jeff Kirchner, RPh. Funding & Team. ICTR Pilot Grant 1UL1RR025011 (Mott) 07/01/11–06/30/12 CTSA program of NCRR/NIH Team Brown County ADRC Streu’s Pharmacy, Green Bay

Download Presentation

Preventing Falls Among Older Adults: The Role of the Community Pharmacist

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Preventing Falls Among Older Adults: The Role of the Community Pharmacist David A. Mott, PhD Barb Michaels, RN Jeff Kirchner, RPh

  2. Funding & Team • ICTR Pilot Grant • 1UL1RR025011 (Mott) 07/01/11–06/30/12 CTSA program of NCRR/NIH • Team • Brown County ADRC • Streu’sPharmacy, Green Bay • University of Wisconsin- Madison School of Pharmacy • Sonderegger Research Center • University of Wisconsin-Madison School of Medicine • Community Academic Aging Research Network (CAARN)

  3. Motivation for the Study • Falls and Drugs • Fall risk-increasing drugs (FRIDs) • Common use of FRIDs • Stepping On • Medication management workshop

  4. Study Goals • Focus on improving management of medications by Stepping On participants. • The purpose of the study is to test the feasibility of two different methods to modify medication use by Stepping On participants. • The main hypothesis to be tested is whether an individualized, pharmacist-provided MTM session is feasible and will result in more medication modification compared to not providing the pharmacist-led MTM. • Identify barriers and facilitators.

  5. Study Specifics • Study Groups - Random assignment (SO class level) to one of two groups. - Group A (n =40) receives a pamphlet describing strategies to change medication use. - Group B (n = 40) receives the pamphlet as well as meets with a pharmacist to review their medication. • Subjects are followed for six months • Subjects are paid $50.

  6. Study Specifics • All study subjects participate in: • A 60 minute pre- and post-intervention telephone interview to collect health, medication use, and falls history information. • A 30 minute follow-up telephone call every 30 days (a total of five follow-up telephone calls) after the intervention to collect information about medication use and any falls events. Tools provided to subjects to aid recall. • All phone call interviews occur between a student pharmacist and a study subject. Attention is focused on building a relationship, appointment setting, and quality of conversation and data collection. • All conversations with students are audio-recorded.

  7. Study Specifics • Treatment Group • Meet with a pharmacist for 1 hour at a pharmacy located in downtown Green Bay to review their medications. Pharmacist uses patient data collected in interviews and clinical algorithm for FRIDs developed by study personnel and pharmacist. • Pharmacist discusses medication modifications with patient and communicates with prescriber. Pharmacist tracks all modifications. • A telephone follow-up session with the pharmacist occurs about 3 months after the first session. • All conversations with pharmacist are audio-recorded.

  8. Recruitment • Last class session of 7-week Stepping On workshop. • Study is discussed as first topic of session. • Discussion led by IRB-trained study personnel. • Subjects can consent at the session or afterwards following phone call. • Role of ADRC

  9. Recruitment • Results • Recruitment rate to date • Recruitment patterns • Reasons for “yes” and “no”

  10. MTM Session with Pharmacist • Initial patient response • Pharmacist recommendations • Physician follow-up • Patient follow-up

  11. Preliminary Results • Study Enrollment • FRID Use • MTM Impact • Physician response

  12. Questions

More Related